Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.
about
Mechanisms of CFTR Folding at the Endoplasmic ReticulumLMTK2-mediated phosphorylation regulates CFTR endocytosis in human airway epithelial cells.The impact of Cystic Fibrosis Transmembrane Regulator Disruption on cardiac function and stress response.Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotypeLung function imaging methods in Cystic Fibrosis pulmonary diseaseEndoglin in liver fibrogenesis: Bridging basic science and clinical practiceCystic fibrosis transmembrane conductance regulator chloride channel blockers: Pharmacological, biophysical and physiological relevance.Tgf-β1 inhibits Cftr biogenesis and prevents functional rescue of ΔF508-Cftr in primary differentiated human bronchial epithelial cells.PharmGKB summary: very important pharmacogene information for CFTRMicrobiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy.Role of IL-1β in experimental cystic fibrosis upon P. aeruginosa infection.Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies.Modulation of Chloride Channel Functions by the Plant Lignan Compounds Kobusin and Eudesmin.Repeatability and Diagnostic Value of Nasal Potential Difference in a Genetically Admixed Population.Tissue-specific control of CFTR endocytosis by Dab2: Cargo recruitment as a therapeutic target.c-Cbl reduces stability of rescued ∆F508-CFTR in human airway epithelial cells: Implications for cystic fibrosis treatment.Mutation spectrum of Egyptian children with cystic fibrosis.Repairing mutated proteins--development of small molecules targeting defects in the cystic fibrosis transmembrane conductance regulator.Functional architecture of the CFTR chloride channel.Ion/water channels for embryo implantation barrier.Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review.Strategies in early clinical development for the treatment of basic defects of cystic fibrosis.Targeting Nonsense Mutations in Diseases with Translational Read-Through-Inducing Drugs (TRIDs).Structural Changes Fundamental to Gating of the Cystic Fibrosis Transmembrane Conductance Regulator Anion Channel Pore.CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.The TAK1→IKKβ→TPL2→MKK1/MKK2 Signaling Cascade Regulates IL-33 Expression in Cystic Fibrosis Airway Epithelial Cells Following Infection by Pseudomonas aeruginosa.Investigation of the multifaceted iron acquisition strategies of Burkholderia cenocepacia.Metal bridges illuminate transmembrane domain movements during gating of the cystic fibrosis transmembrane conductance regulator chloride channel.PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis.Relative contribution of different transmembrane segments to the CFTR chloride channel pore.An update on new and emerging therapies for cystic fibrosis.Nasospheroids permit measurements of CFTR-dependent fluid transport.KCNK3: new gene target for pulmonary hypertension?Location of a permeant anion binding site in the cystic fibrosis transmembrane conductance regulator chloride channel pore.Detection of CFTR protein in human leukocytes by flow cytometry.Selective targeting of collagen IV in the cancer cell microenvironment reduces tumor burden.Nutrition Status Parameters and Hydration Status by Bioelectrical Impedance Vector Analysis Were Associated With Lung Function Impairment in Children and Adolescents With Cystic Fibrosis.Phosphorylation of cystic fibrosis transmembrane conductance regulator (CFTR) serine-511 by the combined action of tyrosine kinases and CK2: the implication of tyrosine-512 and phenylalanine-508.A new compound heterozygous CFTR mutation in a Chinese family with cystic fibrosis.Population Pharmacokinetics of Amikacin in Adult Patients with Cystic Fibrosis
P2860
Q21129277-BE788BAC-D343-4481-B99C-3A02D47FB944Q30412916-2D8B952E-F5BD-42D4-9CB4-168C5C438EC2Q30692395-C99938A1-1267-4E7F-A3BE-80DC1053684CQ33633486-D26A9661-74C8-4D9A-A32B-AE642058DF9DQ33702900-117F358B-EA75-4851-972C-E8F1B78EC625Q33728841-47BF0A1F-0848-419E-BC52-2497CEEA1883Q34408604-0E28F888-E428-4A41-864B-B0CDCAB9B65CQ34721046-F6111012-F3AC-4AF3-805A-567F26CD83A5Q35108743-E6858F3D-4F9C-41FE-9B57-FEE723D37DF1Q35124580-5C3DA35A-09F8-4BB8-85ED-2FE6878B9ACAQ35513939-B7E6EB79-4B68-4510-888D-CF5D3629819CQ35862783-661B0C18-7747-499F-BB69-7E265C6DD5D9Q36316757-96F66863-E478-4AC4-8944-51F609A7BFD1Q36364754-6747005E-F167-4470-A5D0-E9028C7C230BQ36411793-B29F779A-FA9E-4DD4-A106-2D904B8DC89EQ36721425-65126D3B-A0F6-4CAF-B595-E64984FB30E5Q36984890-81D28E87-E007-493E-A8E8-22A208CE2FCAQ38097952-D50595C1-1FD2-40FC-ADA5-9D45A940C58AQ38171539-26EC3456-7E62-433F-99AE-ACD1E750FDD9Q38208806-0584D4F7-2A8A-4470-90DB-F32328A615B3Q38273318-5D3A93B6-E598-4099-8FEA-9E05F4974A7BQ38733938-A25E9BAB-FB85-4A6A-8D69-7F4CA0A9A623Q38737126-F85B5212-B8F3-4757-B275-EBA26DE655C0Q38867225-83783F4E-FBEC-428F-B4BE-9D5B6C2487FFQ39284204-58C7EF57-CD5A-40DB-8A48-24DADE7AD87AQ40823404-F93970C9-702F-4E4B-A3DE-DB3A99BD0C8EQ41335309-BA2B6C6A-7195-4DBB-BC33-5FE837D426EFQ41860473-AC6D2E22-4B73-47E2-A573-A3F5423F712DQ42325938-6D7F6F61-B7D8-4228-81E5-6ABDFAC006E7Q42614303-EEDB8F41-F11D-428C-A51E-563F3E20C595Q47652015-A04A4DFD-7F53-4D63-B6CC-6DB02A588F60Q47657423-9AF01EC5-BB82-44E3-B032-C741D061D8A1Q51729363-6065CEB1-3F15-4A4E-85B6-244027CAB3BBQ51744580-BDAC5010-C4CE-4701-845A-EAA9607EC67AQ53093562-A327D6B2-9082-4366-87E7-16E9B63F0E2AQ53701936-2FDCD0B6-CBD1-4728-B53B-993CD27AF4B4Q53795351-A5D624F3-2895-4FFC-A999-EFEBCB8B7955Q54399767-34F25F85-6852-42BA-A802-84CF3B2183DFQ54741231-72330D17-353D-4233-A7CD-15780B7B3110Q57151052-1E4D63D2-406C-4480-BBCC-9F22FC4D709C
P2860
Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.
@ast
Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.
@en
Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.
@nl
type
label
Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.
@ast
Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.
@en
Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.
@nl
prefLabel
Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.
@ast
Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.
@en
Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.
@nl
P2093
P921
P1476
Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy
@en
P2093
Barbara Dhooghe
Bob Lubamba
Teresinha Leal
P304
P356
10.1016/J.CLINBIOCHEM.2012.05.034
P50
P577
2012-06-12T00:00:00Z